Gastro One is a clinical research site located in Cordova, Tennessee, United States 38018.
Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.
Gastro One has participated in 11 clinical trials with 7 currently active.
Therapeutic areas: Moderately to Severely Active Ulcerative Colitis, Primary Biliary Cholangitis, Ulcerative Colitis.
Sponsors: Hoffmann-La Roche, Intercept Pharmaceuticals, Eli Lilly and Company.
Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Gastro One has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Gastro One has 11 clinical trials on record, with 7 currently active. Their work covers Moderately to Severely Active Ulcerative Colitis, Primary Biliary Cholangitis, Ulcerative Colitis.
Yes — Gastro One holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.